Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.06 - $4.25 $32,754 - $67,575
-15,900 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$3.3 - $5.44 $107,474 - $177,169
-32,568 Reduced 67.19%
15,900 $67,000
Q4 2021

Feb 11, 2022

SELL
$4.56 - $10.56 $35,257 - $81,649
-7,732 Reduced 13.76%
48,468 $253,000
Q3 2021

Nov 12, 2021

SELL
$9.9 - $11.72 $514,354 - $608,912
-51,955 Reduced 48.04%
56,200 $619,000
Q2 2021

Aug 13, 2021

BUY
$9.02 - $12.93 $544,862 - $781,049
60,406 Added 126.51%
108,155 $1.13 Million
Q1 2021

May 13, 2021

BUY
$10.56 - $13.94 $504,229 - $665,621
47,749 New
47,749 $579,000
Q3 2020

Nov 13, 2020

SELL
$9.3 - $25.16 $82,770 - $223,924
-8,900 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$15.99 - $22.88 $142,311 - $203,632
8,900 New
8,900 $204,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.